Highly increased maspin expression corresponds with up-regulation of miR-21 in endometrial cancer: A preliminary report

International Journal of Gynecological Cancer

Volumn 21, Issue 1, 2011, Pages 8-14

  Torres, Anna ^a,b   Torres, Kamil ^a,c   Paszkowski, Tomasz ^b   Radej, Sebastian ^a   Staśkiewicz, Grzegorz J ^a,b   Ceccaroni, Marcello ^d,e   Pesci, Anna ^e   Maciejewski, Ryszard ^a,b,f  

^a Laboratory of Biostructure   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c Lublin County Specialist Hospital   (Poland)

^d International School of Surgical Anatomy   (Italy)

^e Sacred Heart Hospital   (Italy)

^f Medical Emergency Department   (Poland)

Author keywords

Endometrial cancer; Maspin; MiR 21; PDCD4

Indexed keywords

MASPIN; MICRORNA 21; PROGRAMMED DEATH 1 LIGAND 2;

ADULT; ARTICLE; BODY MASS; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MYOMETRIUM; OUTCOME ASSESSMENT; PARITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; APOPTOSIS REGULATORY PROTEINS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SERPINS; STATISTICS, NONPARAMETRIC; UP-REGULATION;

EID: 79951488465     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318200050e     Document Type: Article

References (28)

1. US Cancer Statistics. 1999-2005 Incidence and mortality Web-based report. Available at: http://www.cdc.gov/uscs. Accessed April 12, 2010.
2. Prat J, Gallardo A, Cuatrecasas M, et al. Endometrial carcinoma: pathology and genetics. Pathology. 2007;39:72-87.
3. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 1994;263:526-529. (Pubitemid 24082753)
4. Yang HS, Cho MH, Zakowicz H, et al. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol. 2004;24:3894-3906. (Pubitemid 38496167)
5. Wei ZT, Zhang X, Wang XY, et al. PDCD4 inhibits the malignant phenotype of ovarian cancer cells. Cancer Sci. 2009;100:1408-1413.
6. Hall DC, Johnson-Pais TL, Grubbs B, et al. Maspin reduces prostate cancer metastasis to bone. Urol Oncol. 2008;26:652-658.
7. Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res. 2002;8:2924-2932. (Pubitemid 35025740)
8. Tsuji T, Umekita Y, Ohi Y, et al. Maspin expression is up-regulated during the progression of endometrioid endometrial carcinoma. Histopathology. 2007;51:871-874. (Pubitemid 350179410)
9. Visone R, Croce CM. MiRNAs and cancer. Am J Pathol. 2009;174:1131-1138.
10. Lu Z, Liu M, Stribinskis V, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 2008;27:4373-4379. (Pubitemid 352010003)
11. Zhu S, Wu H, Wu F, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008;18:350-359. (Pubitemid 351333899)
12. Boren T, Xiong Y, Hakam A, et al. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol. 2008;110:206-215.
13. Wu W, Lin Z, Zhuang Z, et al. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma. Eur J Cancer Prev. 2009;18:50-55.
14. Cohn DE, Fabbri M, Valeri N, et al. Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol. 2010;202:656.e1-656. e8.
15. Hiroki E, Akahira J, Suzuki F, et al. Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci. 2010;101:241-249.
16. Pfaffl MW, Horgan GW, Dempfle L. Relative Expression Software Tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
17. Bettstetter M, Woenckhaus M, Wild PJ, et al. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol. 2005;205:606-614. (Pubitemid 40514834)
18. Umekita Y, Yoshida H. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma. Histopathology. 2003;42:541-545. (Pubitemid 36688147)
19. Li HW, Leung SW, Chan CS, et al. Expression of maspin in endometrioid adenocarcinoma of endometrium. Oncol Rep. 2007;17:393-398.
20. Murai S, Maesawa C, Masuda T, et al. Aberrant maspin expression in human endometrial cancer. Cancer Sci. 2006;97:883-888. (Pubitemid 44151269)
21. Stark AM, Schem C, Maass N, et al. Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status. Neurol Res. 2010;32:303-308.
22. Cheng AM, Byrom MW, Shelton J, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 2005;33:1290-1297. (Pubitemid 41439922)
23. Lui WO, Pourmand N, Patterson BK, et al. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007;67:6031-6043. (Pubitemid 47037482)
24. Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007;120:1046-1054. (Pubitemid 46214304)
25. Pan Q, Luo X, Toloubeydokhti T, et al. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod. 2007;13:797-806. (Pubitemid 350131353)
26. Shao ZM, Radziszewski WJ, Barsky SH, et al. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. Cancer Lett. 2000;157:133-144. (Pubitemid 30629024)
27. Iorio MV, Visone R, Di Leva G, et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007;67:8699-8707. (Pubitemid 47437445)
28. Zhang Z, Li Z, Gao C, et al. miR-21 Plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest. 2008;88:1358-1366.